SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Neurocrine Biosciences Q1 EPS $0.390 Misses $0.540 Estimate, Sales $237.100M Beat $223.870M Estimate

Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $0.390 per share which missed the analyst consensus estimate of $0.540 by 27.78 percent. This is a 134.82 percent increase over losses of $(1.120) per

Benzinga · 05/06/2020 20:27

Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $0.390 per share which missed the analyst consensus estimate of $0.540 by 27.78 percent. This is a 134.82 percent increase over losses of $(1.120) per share from the same period last year. The company reported quarterly sales of $237.100 million which beat the analyst consensus estimate of $223.870 million by 5.91 percent. This is a 71.31 percent increase over sales of $138.403 million the same period last year.